Community
Valor Overseas Trading Expands Commercial Purchasing and Merchant Supply for A7 Aluminium Ingots and UBC Scrap
By Maya Thompson
Johnson & Johnson announces ICOTYDE® (icotrokinra) delivers significant improvement in psoriatic arthritis disease activity among biologic-naive patients with once-daily targeted oral peptide
Maya Thompson
Maya Thompson
Bureau Chief · Chagrin Falls, OH
Maya Thompson has over 15 years of experience in local journalism, serving as the lead reporter for the Chagrin Valley Times before taking on her current role at Chagrin Falls Current. She holds a Master's in Journalism from Ohio University and has covered a range of local issues, with a focus on community engagement and development.
More from Maya →Bureau Chief · Saturday, November 7, 2026 at 3:03 PM · 1 min read
Late-breaking data from Phase 3 investigational study presented at the American College of Rheumatology Convergence show 58% of ICOTYDE-treated patients achieved an ACR20 response and 29% achieved an ACR50 response at Week 16ICOTYDE is a first-in-class IL-23R targeted oral peptide,…
Up nextValor Overseas Trading Expands Commercial Purchasing and Merchant Supply for A7 Aluminium Ingots and UBC ScrapCommunity · 1 min read
